Skip to Content
Merck
CN

346330

Sigma-Aldrich

trans-3-Bromo-N-ethylcinnamamide

99%

Sign Into View Organizational & Contract Pricing

Select a Size

About This Item

Linear Formula:
BrC6H4CH=CHCONHC2H5
CAS Number:
58473-74-8
Molecular Weight:
254.12
MDL number:
MFCD00075351
UNSPSC Code:
12352100
PubChem Substance ID:
24861397

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Assay

99%

mp

89-91 °C (lit.)

SMILES string

CCNC(=O)\C=C\c1cccc(Br)c1

InChI

1S/C11H12BrNO/c1-2-13-11(14)7-6-9-4-3-5-10(12)8-9/h3-8H,2H2,1H3,(H,13,14)/b7-6+

InChI key

LDCXGZCEMNMWIL-VOTSOKGWSA-N

Looking for similar products? Visit Product Comparison Guide

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H315,H319,H335

Precautionary Statements

P261 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
10231CW
13326DW

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

E A Lane et al.
Journal of pharmaceutical sciences, 72(5), 493-496 (1983-05-01)
Fifty percent of a cinromide dose was metabolized to an active metabolite in the rhesus monkey. The steady-state concentration of this metabolite was 3-6 times that of the parent drug, depending on the route of administration. Cinromide is a medium-extraction
Prediction of steady-state behavior of metabolite from dosing of parent drug.
E A Lane et al.
Journal of pharmaceutical sciences, 69(5), 610-612 (1980-05-01)
A J Wilensky et al.
Epilepsia, 24(4), 401-409 (1983-08-01)
Monotherapy with the experimental antiepileptic drug cinromide was evaluated in 11 adult outpatients with uncontrolled partial epilepsy. They were treated with phenytoin for 2 months, cinromide for 4 months, and carbamazepine for 4 months. Four patients withdrew from the study
E A Lane et al.
Journal of pharmaceutical sciences, 72(11), 1352-1354 (1983-11-01)
The dose-dependent nonlinearity of the clearance of cinromide, a medium extraction ratio drug, has been established in two monkeys. Special problems encountered in evaluation of nonlinearity of such drugs were resolved by the experimental design: cinromide was infused to steady
E A Lane et al.
Journal of pharmacokinetics and biopharmaceutics, 13(4), 373-386 (1985-08-01)
A previous study of the metabolic fate of cinromide (3-bromo-N-ethylcinnamamide) in rhesus monkey established that half of a dose is metabolized by N-deethylation to an active metabolite, 3-bromocinnamamide. Both cinromide and its proximal metabolite can be metabolized by amide hydrolysis
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service